Screener
Arcus Biosciences RCUS Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development (Includes $2, $11, $2 and $6 from a related party) | 113 | 139 | 235 | 261 |
| General and administrative(Includes $—, $2, $— and $2 from a related party) | 24 | 29 | 53 | 57 |
| Total operating expenses | 137 | 168 | 288 | 318 |
| Loss from operations | (96) | (8) | (230) | (130) |
| Non-operating income (expense): | ||||
| Interest and other income, net | 8 | 10 | 17 | 21 |
| Interest expense | (3) | (2) | (6) | (3) |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's other operating expenses?
- Arcus Biosciences (RCUS) reported other operating expenses of $137M in Q2 2026.
- How has Arcus Biosciences's other operating expenses changed year-over-year?
- Arcus Biosciences's other operating expenses decreased by 18.5% year-over-year, from $168M to $137M.
- What is the long-term trend for Arcus Biosciences's other operating expenses?
- Over 4 years (2021 to 2025), Arcus Biosciences's other operating expenses has grown at a 17.8% compound annual growth rate (CAGR), from $329M to $633M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Arcus Biosciences's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude